#United States #Baird Medical #microwave ablation #Milwaukee #AAES Annual Meeting

Baird Medical's Participation in the AAES 2025 Annual Meeting

Baird Medical Investment Holdings Ltd., known for its pioneering work in minimally invasive Microwave Ablation (MWA) technology, is excited to announce its involvement in the upcoming 45th Annual Meeting of the American Association of Endocrine Surgeons (AAES). This significant event will be held from May 17 to 19, 2025, at the Baird Center located in Milwaukee, Wisconsin.

As a prominent gathering for endocrine surgeons in North America, the AAES Annual Meeting serves as a platform for industry leaders, clinicians, researchers, and trainees to come together, discuss advancements, and share knowledge aimed at enhancing the practice of endocrine surgery. The meeting focuses on various critical areas, including thyroid diseases, parathyroid, adrenal glands, and the endocrine pancreas, thereby facilitating collaborative discussions on cutting-edge research and innovative treatment techniques.

Baird Medical's presence at this prestigious conference underscores the rising importance of MWA technology, especially regarding minimally invasive options for treating endocrine conditions, such as thyroid nodules. The company recognizes this event not only as an opportunity to showcase its advanced MWA systems but also as a chance to engage with key opinion leaders in the field and gather insights that could influence the future direction of patient care strategies.

"The AAES Annual Meeting presents an invaluable opportunity to stay abreast of surgical advancements and evolving clinical trends in endocrine care," said a representative from Baird Medical. "We are committed to advancing patient care through our cutting-edge technologies and strategic collaborations within the endocrine surgery community."

At the AAES 2025, Baird Medical will be engaging in discussions that are essential for shaping future surgical practices. The company plans to present clinical updates surrounding its MWA solutions, which have been integral in providing more efficient and effective treatment options for patients. Furthermore, Baird Medical aims to foster valuable collaborations that will push the boundaries of innovation in surgical techniques.

Baird Medical's mission centers around improving patient outcomes. The company is not only dedicated to developing minimally invasive surgical instruments and robotic systems but also strives to implement intelligent solutions that enhance diagnostic decisions and preventive healthcare strategies. With their FDA 510(k) certification, Baird Medical's products are currently utilized in over 30 leading healthcare institutions across the United States, including renowned hospitals like Johns Hopkins and Weill Cornell Medicine. Moreover, Baird Medical holds a significant market position in China, particularly regarding thyroid MWA devices.

The company's involvement at the AAES meeting aligns with its broader vision of promoting advancements in endocrine surgery through continuous research and development. Participation in this forum allows Baird Medical to contribute to the ongoing scientific exchange and align its efforts with other stakeholders who aspire to elevate patient care in endocrine health.

In summary, Baird Medical is looking forward to its participation in the AAES 2025 Annual Meeting. By engaging in this premier event, the company aims to support the endocrine surgery community while showcasing its innovations and commitment to improving patient care through minimally invasive procedures. Together, Baird Medical and the AAES members can pave the way for the future of endocrine surgery, ensuring patients receive the best possible care through advanced medical technologies and collaborative efforts.